Skip to main content
Front of HEC

School of Medicine

From driving cutting-edge research to bringing medical innovations to market, landing competitive awards and more, the faculty, staff and students at Case Western Reserve University School of Medicine know how to make headlines.

Recent News

Musil%20Hickman%2C%20Voss%20Griffin%20with%20FPB%20alumni%20and%20colleagues.JPG
CWRU’s work with Microsoft HoloLens highlighted
Outlet: Cleveland Magazine
Company founded by CWRU’s Paul Tesar, Drew Adams partners with Genentech
Outlet: Crain's Cleveland Business
A New Pathway: Researchers Identify Potential Treatment Target for Crohn’s Disease
There is no cure for the more than 1.6 million people in the United States living with Crohn’s disease (CD) and its symptoms, including abdominal pain, intestinal distress and severe weight-loss. CD is a form of inflammatory bowel disease (IBD) in which the body’s own immune system attacks the…
website
Keeping do-it-yourself gene science safe
CWRU team will provide policy recommendations for balancing safety, innovation While federal and professional regulatory systems monitor genetic-editing experiments in university and corporate labs, most research conducted outside of these settings lacks formal oversight. Now, two Case Western…
Back of an ICE policeman's uniform
School of Medicine Director of Admissions Christian Essman weighs in on med school admissions process
An admissions director on putting your best foot forward Medical School Headquarters: Christian Essman, director of admissions at the School of Medicine, weighed in on the medical school admissions process and gave tips to students as they navigate the application process.
Case Western Reserve School of Medicine Scientist Receives Major Grant for Diagnosis of Alzheimer’s, Parkinson’s Via New Skin Test
Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer’s disease, Parkinson’s disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive…
brain-scan-feat
Case Western Reserve ‘spinout’ company, Convelo Therapeutics, partners with Genentech to develop medicines for neurological disorders
Convelo Therapeutics Inc., a Cleveland company based on the research findings of Paul Tesar and Drew Adams at the Case Western Reserve University School of Medicine, has entered into a strategic partnership with Genentech to develop new therapeutic drugs to repair damaged myelin insulation on nerve…
Researchers Discover New Combination Therapy to Treat Drug-Resistant Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia accounts for one in five adult leukemias, and is the most common pediatric cancer in the United States. While new immune therapies have helped improve survival rates, some patients are unresponsive to existing treatment regimens. In addition, drug-related toxicities and…